BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4389248)

  • 21. 6 -amidinopenicillanic acids--a new group of antibiotics.
    Lund F; Tybring L
    Nat New Biol; 1972 Apr; 236(66):135-7. PubMed ID: 4402006
    [No Abstract]   [Full Text] [Related]  

  • 22. Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program.
    Beekmann SE; Heilmann KP; Richter SS; GarcĂ­a-de-Lomas J; Doern GV;
    Int J Antimicrob Agents; 2005 Feb; 25(2):148-56. PubMed ID: 15664485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro comparison of erythromycin, lincomycin, and clindamycin.
    Phillips L; Fernandes R; Warren C
    Br Med J; 1970 Apr; 2(5701):89-90. PubMed ID: 4988120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of the ketolide ABT-773.
    Barry AL; Fuchs PC; Brown SD
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2922-4. PubMed ID: 11557491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antibiotic activity of the methacycline-triacetyl-oleandomycin association].
    Ambrosoli G; Ciarlini E; Lazzarini L
    Antibiotica; 1966 Sep; 4(3):169-89. PubMed ID: 4384277
    [No Abstract]   [Full Text] [Related]  

  • 26. Laboratory and clinical evaluation of rifampicin.
    Atlas E; Turck M
    Am J Med Sci; 1968 Oct; 256(4):47-54. PubMed ID: 4387028
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibiotic resistance in general practice.
    Hammond L
    Aust Fam Physician; 1990 May; 19(5):723-4, 727, 730-1. PubMed ID: 2111984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan.
    Hsueh PR; Shyr JM; Wu JJ
    Clin Microbiol Infect; 2006 Mar; 12(3):296-8. PubMed ID: 16451421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multiresistant bacteria in a Scandinavian perspective].
    Kristinsson KG
    Nord Med; 1995; 110(2):42-4, 54. PubMed ID: 7854908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Erythromycin sensitivity of bacterial strains isolated in a hospital].
    Bradimarte C; Altieri T; Filocamo G
    Minerva Pediatr; 1978 Jan; 30(2):179-80. PubMed ID: 25374
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden.
    Kallings I; Bengtsson S; Christensen P; Holm SE; Lind L; Kalin M
    Scand J Infect Dis Suppl; 1983; 39():100-5. PubMed ID: 6359377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of clindamycin and other antimicrobials against gram-positive bacteria and Hemophilus influenzae.
    Marks MI
    Can Med Assoc J; 1975 Jan; 112(2):170-3. PubMed ID: 234287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
    Nord CE; Lindmark A; Persson I
    J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
    [No Abstract]   [Full Text] [Related]  

  • 34. Antimicrobial susceptibility patterns of Haemophilus influenzae and Streptococcus pneumoniae isolates in a Beirut general university hospital between 2000 and 2004.
    Daoud Z; Cocozaki A; Hakime N
    Clin Microbiol Infect; 2006 Jan; 12(1):86-90. PubMed ID: 16460553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antibacterial activity in vitro of a new rifamycin: rifamide].
    Monnier J; Bourse R
    Pathol Biol; 1968 Oct; 16(19):901-8. PubMed ID: 4972879
    [No Abstract]   [Full Text] [Related]  

  • 36. [Sensitivity test of clinical isolates to fusidic acid].
    Kobayashi M; Yamamoto S; Takami H; Mihara K
    Jpn J Antibiot; 1971 Jun; 24(3):152-5. PubMed ID: 4397858
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results.
    Biedenbach DJ; Jones RN; Lewis MT; Croco MA; Barrett MS
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):275-82. PubMed ID: 10212755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibacterial activity of nine oral antibiotics against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis.
    Renkonen OV
    Scand J Infect Dis Suppl; 1983; 39():106-8. PubMed ID: 6606222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative in vitro activity of amoxicillin and ampicillin against bacteria isolated from ill children.
    Marks MI
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1137-44. PubMed ID: 4154827
    [No Abstract]   [Full Text] [Related]  

  • 40. [Multicenter study of the in vitro effect of imipenem (N-formimidoyl-thienamycin) on hospital bacteria].
    Soussy CJ; Otterbein G; Le Van Thoi J; Thabaut A; Meyran M; Courtieu AL; Reynaud A; Dabernat H; Lareng MB; Chanal M
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):487-92. PubMed ID: 3911142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.